Bone Sialoprotein (BSP), Y278-D295 Antibody from KERAFAST, INC.

Search, find, compare suppliers for anti-Bone Sialoprotein (BSP), Y278-D295 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityBone Sialoprotein (BSP), Y278-D295
CloneLF-84
Host SpeciesRabbit
Reactive Specieshuman and most mammals
Isotypen/a
Formatunconjugated
Size100uL
Concentrationn/a
ApplicationsWB 1:2000, IHC 1:200
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Bone Sialoprotein (BSP), Y278-D295 [LF-84] Antibody. Target: Bone Sialoprotein (BSP), human. Epitope: YESENGEPRGDNYRAYED
ImmunogenPeptide
Other Namesn/a
Gene, Accession #Accession: P21815
Catalog #ENH076-FP
Price$336
Order / More InfoBone Sialoprotein (BSP), Y278-D295 Antibody from KERAFAST, INC.
Product Specific References
  1. Fisher LW, Stubbs JT 3rd, Young MF. Antisera and cDNA probes to human andcertain animal model bone matrix noncollagenous proteins. Acta Orthop ScandSuppl. 1995 Oct;266:61-5. PubMed PMID: 8553864.
  2. Jeong-Seok Nam, Adam M. Suchar, Mi-Jin Kang, Christina H. Stuelten, Binwu Tang, Aleksandra M. Michalowska, Larry W. Fisher, Neal S. Fedarko, Alka Jain, Jan Pinkas, Scott Lonning, Lalage M. Wakefield. Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of TGF-? in a mouse model of breast cancer. Cancer Res. 2006 Jun 15; 66(12): 63276335.
  3. Miwa HE, Gerken TA, Jamison O, Tabak LA. Isoform-specific O-glycosylation of osteopontin and bone sialoprotein by polypeptide N-acetylgalactosaminyltransferase-1. J Biol Chem. 2010 Jan 8;285(2):1208-19.
  4. Karadag A, Ogbureke KU, Fedarko NS, Fisher LW. Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion.J Natl Cancer Inst. 2004 Jun 16;96(12):956-65.
  5. Calloni GW, Le Douarin NM, Dupin E. High frequency of cephalic neural crest cells shows coexistence of neurogenic, melanogenic, and osteogenic differentiation capacities. Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):8947-52
  6. Ogbureke KU, Abdelsayed RA, Kushner H, Li L, Fisher LW. Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma. Cancer. 2010 Apr 1;116(7):1709-17.
  7. Ogbureke KU, Fisher LW. Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). Kidney Int. 2005 Jul;68(1):155-66.
  8. Knabe C, Kraska B, Koch C, Gross U, Zreiqat H, Stiller M. A method for immunohistochemical detection of osteogenic markers in undecalcified bone sections. Biotech Histochem. 2006 Jan-Feb;81(1):31-9.
  9. Yamauchi N, Nagaoka H, Yamauchi S, Teixeira FB, Miguez P, Yamauchi M. Immunohistological characterization of newly formed tissues after regenerative procedure in immature dog teeth. J Endod. 2011 Dec;37(12):1636-41
KERAFAST, INC.
KERAFAST, INC.
KERAFAST, INC.
An Absolute Biotech Company
2 Shaker Road, Unit B101
Shirley MA 01464
P: +1-617-336-3228
P: +1-800-546-1760
F: +1-866-727-9826

info@kerafast.com
Tech Support: TechnicalSupport@kerafast.com

https://www.kerafast.com
Profile of KERAFAST, INC.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.